APT Medical Inc.

Shanghai Stock Exchange 688617.SS

APT Medical Inc. Return on Equity (ROE) for the year ending December 31, 2023: 28.00%

APT Medical Inc. Return on Equity (ROE) is 28.00% for the year ending December 31, 2023, a 37.89% change year over year. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.

APT Medical Inc. Return on Equity (ROE) for the year ending December 31, 2022 was 20.30%, a 73.64% change year over year.
APT Medical Inc. Return on Equity (ROE) for the year ending December 31, 2021 was 11.69%, a -51.41% change year over year.
APT Medical Inc. Return on Equity (ROE) for the year ending December 31, 2020 was 24.06%, a 1.87% change year over year.
APT Medical Inc. Return on Equity (ROE) for the year ending December 31, 2019 was 23.62%, a 196.29% change year over year.

Key data

Date	Return on Equity (ROE)	Return on Capital Employed (ROCE)	Interest Coverage Ratio	Debt to Equity Ratio

Shanghai Stock Exchange: 688617.SS

APT Medical Inc.

CEO	Mr. Zhenghui Cheng
IPO Date	Jan. 7, 2021
Location	China
Headquarters	601, Building B
Employees	2,155
Sector	Healthcare
Industries Medical Instruments 3D Printing Automotive Parts Biotechnology Clinical Trials Hardware & Electronics Pharmaceuticals Robotics

Description

APT Medical Inc. engages in the research and development, manufacture, and sale of invasive interventional medical devices for cardiovascular and cerebrovascular diseases worldwide. The company offers electrophysiological catheter delivery systems, as well as radiofrequency ablation and mapping catheters; and vascular intervention products, such as diagnostic and treatment products, and intervention accessories. It also provides OEM/ODM services to catheter and metal products, as well as accessories. The company was founded in 2002 and is headquartered in Shenzhen, China.

Key trends

Past 5 years